Eric Merola’s 6th feature documentary:

Ukraine: Fetal Stem Cell Pioneers

Watch new free on YouTube

Contributions are tax deductible under the 501(c)(3) IRS code.

This page is best viewed on a desktop, laptop, or tablet

Questions?  [email protected]

I have been working with From The Heart Productions since 2014 to help fund my documentaries. They are dedicated to helping independent filmmakers, like me, who make positive contributions to society. They fully support my work investigating and documenting fetal stem cell technology and my upcoming release of Ukraine: Fetal Stem Cell Pioneers

From The Heart Productions is a fully 501(c)(3) IRS compliant organization. All contributions processed through From The Heart Productions qualify for a tax exemption. They take 5% of each contribution for their administration fee. All transactions are audited to make sure all money contributed was spent as intended on this project.

Contributions made by check must be made payable to: From The Heart Productions
Important: You must write “For: Fetal Stem Cell Pioneers” on the MEMO of the check. 
Mail to: From The Heart Productions, 1013 Harbor Blvd., #53, Oxnard, CA 93035

Tax deductible 501(c)(3) contributions can also be made online here. (Note: 8% administrative fee will be deducted).

If you wish to make a direct non-tax-exempt contribution via PayPal please click here to contribute to me directly.

Questions? Email me: [email protected]


Full summary of the contents of Ukraine: Fetal Stem Cell Pioneers

Please take advantage of the image slideshows for each section

History and the discovery of fetal stem cells as a therapy

Like all scientific discoveries, they are usually found by accident, followed by scientific research and extensive testing. With fetal stem cells, it’s all of the above. In 1893, a German pathologist named George Schmorl was the first to discover that fetal cells migrate outside of the womb and into the mother host during pregnancy. Since then, scientists from around the world have ubiquitously verified his discovery and realized that these fetal cells not only migrate outside of the womb, but they repair, protect, and regenerate tissues within the mother during pregnancy. This has been further proven from autopsies of donated female cadavers who had given birth to male children decades earlier—scientists consistently found male DNA in the hearts and brains of these women. They also found evidence of repair and regeneration at the site of the discoveries—such as the repair of congenital heart defects after pregnancy.

It took a tragedy to open the doors for fetal stem cells

In 1986, Ukraine and the surrounding region suffered from a nuclear accident at Chernobyl. Many of those in the immediate area suffered from aplastic anemia, (bone marrow failure). Many were living off of blood transfusions waiting for bone marrow transplants to survive. However, due to the magnitude of the accident, finding a bone marrow match, or even a suitable donor, had become nearly impossible. So scientists resorted to injecting fetal liver cells into these patients. The reason being is the fetal liver at the end of the first trimester (7-12 weeks) contains the foundation, the building blocks of the body’s entire bone marrow, and thus the body’s entire blood and immune system. This had never been attempted before, it was a last resort measure to try to save the lives of those suffering from aplastic anemia. 

EmCell’s founders treat first patient, and cure aplastic anemia

Dr. Alexander Smikodub (1949-2009) and Dr. Alexey Karpenko are the original founders of fetal stem cell therapy, and the founders of EmCell. I interview Dr. Karpenko as he explains curing the very first patient they ever treated with fetal stem cells by injecting fetal liver cells into a child with bone marrow failure due to Chernobyl. Neither Karpenko or Smikodub knew for certain if this would work, but it did. To their surprise, this child was cured. I also managed to locate and interview this patient, who is now an adult living in Switzerland with his wife and child. Dr. Karpenko is responsible for helping Ukraine’s Ministry of Health draft the legislation to allow fetal stem cell therapy to be legalized for research and clinical use, based on their work curing aplastic anemia patients after Chernobyl.

Evolving from a single room in a Kyiv hospital into the only fetal stem cell laboratory and clinical facility in the world

After proper regulation and legislation was formulated—EmCell officially opened its doors in 1994 operating out of a single room in a Kyiv state hospital. Since then, they have evolved into a massive state-of-the-art facility unlike anything in the world. 

To this day, EmCell in Kyiv, Ukraine is the only place on earth where people can obtain true fetal stem cell therapy. This is not legal or available in China, Mexico, Panama—it is simply not available anywhere outside of Ukraine. I have looked. 

The abortion issue

I point out that the biggest barrier to fetal stem cell therapy being available anywhere else in the world is due to where they come from: end of first trimester (7-12 weeks) abortions. While interviewing all the patients in the documentary, I ask them their opinion about this issue. They are quick to point out the absurdity of some people assuming women would get pregnant on purpose to support this therapy, when there are already 50 million abortions worldwide to pull the material from. One patient, who is a nurse in the USA, points out that women have been finding ways to end pregnancies since 1000 B.C. 

Tour of EmCell’s new state-of-the-art GMP laboratory

Since curing the first patient with aplastic anemia in 1991, EmCell’s scientists have expanded their extraction process to include virtually all of the organ systems in the human body. I take the audience on an extensive tour of the laboratory documenting the extraction process from the donated fetal material, to the testing for bacterial or viral infections. Once the cells are cleared for safety, they are then sent to quality control to see how well the cells proliferate in the body. They do this by allowing a sample from each batch of cells to proliferate in a petri dish. EmCell’s scientist do not believe in replicating the cells before injection. They do this only to make sure the cells will replicate and proliferate after human injection. It is the fetal stem cells’ proliferation potential after human injection that makes this therapy so powerful. More.

Stages 1-3 of the fetal stem cells production process

I take the audience through the entire production process stage-by-stage: extraction, cryopreservation, and testing for bacteria and/or viruses. They not only test the fetal material itself, but they also test the donor’s blood for any viral or bacterial infections. While I was there, they detected hepatitis C in the donors blood, resulting in EmCell having to completely discard the entire batch of fetal material donated that day. Even if they find contamination in the donors blood, and not in the fetal material from that donor, they still completely discard the fetal material. They discard on average 10% of all the fetal material given to them for various reasons. EmCell has a proprietary method of cryopreservation resulting in 98% of live cells preserved. The average stem cell lab only has 70%-80% of live cells preserved. More.

Stage 4 of the production process: proliferation testing

Perhaps the most exciting part of the tour was witnessing EmCell’s proliferative potential quality control testing process. This is where they allow the cells to grow on their own in a petri dish for weeks or more. They monitor their progress in real time with a microscope. If the cells cannot proliferate in vitro, then they can’t proliferate in the human body after injection. This is one of the most important parts of the production process. The goal is to inject the right amount of cells, and after injection, they then “explode” into a replication and proliferation process, while regenerating any and all tissues in their path. More.

Timelapse and real-time footage of the proliferation testing

The audience will see both real time and time lapse video of live fetal stem cells proliferating—including live beating fetal cardiomyocytes (heart cells), endothelial cells (blood vessel cells) forming their own newly formed vascular system in vitro. Also included is a colony of fetal cardiomyocytes (heart cells) beating in unison in real time. They also explain why embryonic stem cells are dangerous, and how adult or umbilical mesenchymal (blood) cells are greatly inferior to fetal stem cells because a blood or mesenchymal stem cell cannot become an organ cell. With fetal stem cells you are already receiving the organ cells you need to regenerate any organ in its path after injection. They explain why fetal stem cell therapy is the simply the most powerful stem cell therapy in the world.

Muscular Dystrophy: Sophia Jones

There is no treatment or cure for muscular dystrophy. After Jerry Lewis raised more than $2 billion in funding, modern science is no closer to a viable treatment, much less a cure, than it was 50 years ago. This is a genetic mutation causing all muscles, including the lungs, to slowly deteriorate until the patient dies. Sophia Jones was diagnosed with Ullrich Muscular Dystrophy when she was 4 years old. Most are dead by age 10 with this diagnosis, and all who are still alive at this age are in a wheelchair, using a feeding tube, and a respirator to survive. Sophia is now 14 years old and fully independent. Fetal stem cell therapy saved her life. Her mother, Diana, has also been receiving fetal stem cell therapy to rid her Hashimoto’s disease, sjogren’s disease, celiac disease, and thyroid problems. I’ve been documenting Sophia Jones and her family since 2015. Sophia Jones is the only human being of her kind in medical history. However, Sophia requires fetal stem cell therapy either annually or bi-annually to keep her muscular dystrophy at bay and to continue to allow her to live a normal life. 

The proliferation of fetal neuronal cells (brain cells)

There is no other stem cell type known to modern science that can provide true neuronal (brain) cells to a human patient. You can only obtain this by using fetal stem cells. These cells are crucial for treating people with neurological ailments such as Parkinson’s, Multiple Sclerosis, or autism. It is scientifically impossible for adult blood (mesenchymal), or umbilical blood (mesenchymal) stem cells to transform into a neuronal (brain) cell after human injection. Even if an adult or umbilical mesenchymal stem cell is forcibly transformed into a neuronal cell in a petri dish before human injection, their proliferative potential has been wasted before injection. The only way to acquire true neuronal cells to treat a neurological condition is with fetal stem cells. This is one of the single most valuable reasons why fetal stem cell therapy is so powerful.

Parkinson’s: Xavier Degryse

 While I was in Kyiv, Ukraine following Sophia Jones’ story, I met Xavier Degryse for the first time in 2018. He had been diagnosed with Parkinson’s 5 years prior. During my first interview with Xavier he was showing clear signs of trembling in his right hand due to the Parkinson’s. After his first therapy showed positive results, Xavier returned again to EmCell in Ukraine for a second therapy in 2021. I caught up with Xavier at his home in late 2021, and the first thing I noticed was that he no signs of trembling in his right hand. Most Parkinson’s patients are generally prescribed medications, however his medications have not changed since his therapy in 2018. All other Parkinson’s patients are given increased dosages of their medications over time, but not Xavier. He hopes to be able to return to Ukraine for another therapy in the future. 

Parkinson’s: Bill Walczak

Bill is 78 years old. He was diagnosed with Parkinson’s when he was 72. Bill received his first fetal stem cell therapy in 2020. I caught up with Bill in 2021, for this second therapy. Bill has improved remarkably since first starting therapy. I also show how in cases of Parkinson’s how doctors add Dopamine progenitor fetal stem cells to the protocol for Parkinson’s patients. They also inject these and related cells via an intrathecal procedure (spinal injections). I have been following Bill ever since. He now enjoys boxing classes, golf, and remaining active. Click here to watch an extended video clip of Bill receiving therapy at EmCell (Podcast Episode 15). 

Multiple Sclerosis: Lawrence Simon

I first met Lawrence early in my investigative journey for this project. Lawrence was first diagnosed in 2011, and has been receiving fetal stem cell therapy nearly every year since then. Lawrence once required canes to walk. For this section of the documentary, I was given a rare opportunity to interview Lawrence’s doctor during one of his regular physicals. This doctor, Dr. Tawil, had been practicing medicine for 50 years, and has been Lawrence’s doctor for more than 30 years. Dr. Tawil observed Lawrence before his diagnosis, after his diagnosis, and after his sequence of fetal stem cell therapies. What Dr. Tawil had to share with the audience speaks for itself. 

Multiple Sclerosis: Scott Wood

Scott was diagnosed with primary progressive multiple sclerosis in December of 2019. COVID hit the world, and postponed his ability to travel to Ukraine. He finally received his first and only treatment in May, 2021. My interview took place in December, 2021, eight months after his therapy. Not only can Scott drive a car normally again, but he can walk, paint, play guitar, and everything that multiple sclerosis took from him previously. Scott also suffered multiple heart attacks before his multiple sclerosis diagnosis, and has 3 stints in his heart. His cardiologist said his heart is now normal, with no major heart problems. This is due to the holistic nature of fetal stem cell therapy. Scott not only received targeted doses of fetal neuronal cells, but fetal cardiac cells as well. Click here to listen to a podcast with Scott Wood discussing his condition and his experience with fetal stem cells (Podcast episode 14). 

Multiple Sclerosis: Chad Drilling

Chad was diagnosed with an aggressive form of multiple sclerosis in November, 2018. Within 3 months of his diagnosis, he received his first fetal stem cell therapy. Chad returned to Ukraine for his second fetal stem cell therapy in May of 2021. He and his wife has seen marked improvement, one of the most precious things being that Chad is able to hold and take care of his newborn child. They hope to return to Ukraine in the future for additional fetal stem cell treatments. 

Regeneration vs. degenerative diseases

Fetal stem cells regenerate. Regeneration is their primary function. When utilizing most all of the building blocks of all the main organs of the human body by administering up to 24 different types of fetal stem cells, they hold massive regenerative power. However, I explain how I’ve been following fetal stem cell patients since 2014, and I have consistently noticed that the earlier someone receives fetal stem cell therapy for a degenerative disease, the better chance of positive results. This is due to the amount of damage a degenerative disease can cause before finally bringing fetal stem cells into a patient’s life. The less degenerative damage, the better chances for larger regeneration. And upon multiple therapies either annually or bi-annually, the best chances of experiencing remissions and stability will occur. Fetal stem cells regenerate the body. Degenerative diseases degenerate the body. Fetal stem cells are simply fighting against the degenerative process of a neurological or immunological disease. 

Multiple Sclerosis: Heather Davis

As an example of someone who had been living with multiple sclerosis for more than 18 years (note the above summary re: Regeneration vs. degenerative diseases). Heather explains how she had endured a lot of neurological damage before discovering fetal stem cell therapy. Also, as a registered nurse, she was able to articulate this. She was fully aware that she might not see significant gains after one fetal stem cell therapy. However, she did see enough gains to encourage her seek returning for therapy again. She was treated in 2021. 

Autism: Jax Lippincott

I met the Lippincott family in 2019, when Jax was 4 years old. I met them at EmCell, interviewed them before therapy, and followed their progress. Jax was completely nonverbal when I met him, unable to speak a single word. Jax had to utilize a machine where he typed his words to allow the machine to speak for him, to communicate with anyone. Within a week of therapy, Jax amazed his parents by speaking. Within a month, Jax was speaking complete sentences, and even singing along to the radio. Jax received his first round of therapy in 2019, and then had a follow up therapy in 2021. The Lippincott’s feel there is no need for further stem cell therapy, because as far as they are concerned, Jax is now a normal child. 

Autism: Matt Cutter

Matt Cutter, and his mother Amanda, were at EmCell in 2019 at the same time as the Lippincott family, but they had never met. I introduced the two families to one another to allow them to stay in contact after they returned home to the USA. Matt Cutter first received his therapy when he was 7 years old. According to Matt’s parents, therapists, and teachers I interviewed, Matt was: “not restrainable, unable to follow directions, unable to properly communicate, unable to write his own name, unable to properly learn new things”. Matt received his first therapy in 2019, and returned for a second therapy at the same time as the Lippincott family in 2021. Today, Matt has jumped up a full grade in his education, can write normally, communicate normally, and no longer displays the negative behavior he once had before fetal stem cell therapy. Matt’s mother Amanda also received therapy for anti-aging, and her oldest son Sean was cured of severe stomach issues after he received fetal stem cell therapy. 

Day One: Eric Merola’s 6th annual anti-aging therapy

Full detailed overview of exactly what fetal stem cells I received and injection modality for Day One of my therapy. This includes the fetal liver cells (the same cell type that cured aplastic anemia), and I explain that everyone receives the entire array of nearly two dozen stem cell types—but the dosage levels are personalized to each patient. For example: I would not receive the same amount of fetal liver cells as someone suffering from aplastic anemia. My first day of therapy also included fetal eye injections. Overall the first day for everyone’s therapy sets the foundation for the following day or days. Particularly the injection of fetal endothelial cells, which build new capillaries, and small blood vessels and strengthen the inner walls of larger vessels—allowing the cells to reach far throughout our body. 

Day Two: Eric Merola’s 6th annual anti-aging therapy

Full detailed overview of exactly which fetal stem cells I received including the injection modality for Day Two of my therapy. This included a wide array of fetal neuronal stem cells injected subcutaneously, as well as stem cells targeting my gender. I also received fetal lung cells through a new inhalation process where live fetal lung and other stem cells are delivered directly into my lungs. This was designed as a precautionary preventive measure since we live in the age of COVID. However, patients with lung conditions such as COPD can also benefit from this modality of lung stem cell delivery. 

Day Three: Eric Merola’s 6th annual anti-aging therapy

Full detailed overview of exactly what fetal stem cells I received and injection modality for Day Three of my therapy. This included a wide array of additional neuronal cells as well as other fetal stem cells targeting my connective tissue, muscular and skeletal system—all injected subcutaneously. 

Intracoronary procedure: Fetal cardiac cells injected directly into the heart for congestive heart failure

I document the entire medical procedure of the first American in history to receive fetal heart cells injected directly into his heart via an intracoronary.


My average telomere measurements increased by more than 33% — while the percentage of my long telomeres increased by nearly 3000%. 

Click here to watch actual 3 minute clip from movie.

This documentary is now complete.
The conclusion/ending of the story has not yet been updated on this page. 

The above summary explains the first 1 hour and 25 minutes of the current draft edit of Ukraine: Fetal Stem Cell Pioneers. The remainder of the movie will cover (not in this order):
— Review of why fetal are superior, also explaining why “induced pluripotent stem cells” are not the same, and can perhaps be dangerous. 
— Possible interviews with American “fetal stem cell experts”.
— September trip to Ukraine: Eric, Sophia and Diana Jones, and a few others travel to Ukraine for therapy, and I document the entire journey, interview EmCell staff about Russia, people on street, and overall “trip into a war zone” and why these people are willing to risk their lives to go. Ukraine is the only place on earth providing this therapy. Watch a short film of this trip now. 
— Since the Russian invasion, 2 independent sovereign countries might consider the legalization of FSC (recent happenings), I will show the outcome of that.
— During ending credits, everyone in the movie + other FSC patients will speak their mind, similar to this: CLICK HERE.


Subscribe to be notified of updates to: Ukraine: Fetal Stem Cell Pioneers
* indicates required

Have a question? Email Eric Merola

Listen to The God Cells Podcasts

The God Cells: A Fetal Stem Cell Journey and Ukraine: Fetal Stem Cell Pioneers is a documentary series directed and produced by Eric Merola. This is an independent work of investigative journalism, independently financed by Merola Productions, LLC and not affiliated with any outside company or institution.


Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Consent to display content from - Youtube
Consent to display content from - Vimeo
Google Maps
Consent to display content from - Google